Ellevest, Inc. Mirati Therapeutics, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$39.16 - $88.71 $822 - $1,862	21 New	21 $1,000
Q4 2021 Jan 24, 2022	SELL	$132.01 - $190.29 $2,112 - $3,044	-16 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$132.13 - $177.45 $2,114 - $2,839	16 New	16 $3,000
Q1 2021 May 03, 2021	SELL	$158.92 - $221.61 $1,112 - $1,551	-7 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$162.05 - $240.27 $1,134 - $1,681	7 New	7 $2,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.